Both drugs were evaluated for their association with optic nerve and retinal adverse events and compared with metformin, empagliflozin, dulaglutide and insulin
The goal of this assessment is to help you gain clarity about the factors that may influence your experience and outcomes with GLP-1 treatment so you can make informed decisions and move forward with greater confidence
Such evidence, however, is supported by many relevant pre-clinical or mechanistic studies highlighting the neuroprotective and anti-inflammatory activity of these medications
GLP-1 RAs are prioritized for patients with established ASCVD or high CV risk
[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Chavez A.M., Carrasco Barria R., Leon-Sanz M
Some hair loss specialists recommend 1.2 to 1.5 grams per kilogram during active weight loss on GLP-1 medications